 |
| |
 |
| |
 |
HIFU (High Intensity Focused
Ultrasound):
HIFU does not involve surgery but
instead uses a High Intensity Focused
Ultrasound (HIFU) beam which safely
and effectively heats and destroys
pathogenic tissue rapidly with minimal
side effects.
HIFU PROSTATE PROCEDURE
SHOWS LIMITED SIDE EFFECTS
In April 2012 in a research study 42
patients received focal HIFU therapy
delivered to clinically significant cancer
lesions using the Sonablate 500
developed by US HIFU.
The results showed that urinary and
erectile function returned to pre-
treatment levels 12 months after
treatment. None of the men who
completed the trial had urine leak and
just one in ten suffered from poor
erections. Cancer control was
encouraging although this was not the
primary aim of the study. No biopsy
evidence of cancer was identified in
the treated regions in 30 of 39 men
who were biopsied at six months and
36 of the 39 were free of clinically
significant cancer. After re-treatment in
four men, a total of 39 patients had no
imaging evidence of disease at 12
months.
USHIFU is a privately held, venture-
backed healthcare company. US HIFU
is committed to treating prostate
cancer using HIFU with the Sonablate
500, a minimally invasive, outpatient
procedure.
Currently, the device is not approved
in the US but it is available for the
treatment of prostate cancer in more
than 30 countries.
HIFU (HIGH INTENSITY FOCUSED
ULTRASOUND) EQUIPMENTS
Sonalleve MR-HIFU Fibroid Therapy
system by Philips which offers a non-
invasive alternative to the traditional
surgical treatments for uterine fibroids
in women.
Exablate 2000 by Insightec for uterine
fibroids;
Sonablate by Focus for prostate
cancer on trial in US, approved
elsewhere;
Ablatherm by EDAP-TMS for prostate
cancer on trial in US, approved
elsewhere;
OTHER DEVELOPMENTS
Insurance Claims Filing Services (ICFS
– www.icfstx.com) specializes in
assisting US citizens with filing
insurance when care has been
received internationally. They have
had some success in securing
reimbursement for a number of HIFU
patients for procedures done outside
the country.
Ultrasound):
HIFU does not involve surgery but
instead uses a High Intensity Focused
Ultrasound (HIFU) beam which safely
and effectively heats and destroys
pathogenic tissue rapidly with minimal
side effects.
HIFU PROSTATE PROCEDURE
SHOWS LIMITED SIDE EFFECTS
In April 2012 in a research study 42
patients received focal HIFU therapy
delivered to clinically significant cancer
lesions using the Sonablate 500
developed by US HIFU.
The results showed that urinary and
erectile function returned to pre-
treatment levels 12 months after
treatment. None of the men who
completed the trial had urine leak and
just one in ten suffered from poor
erections. Cancer control was
encouraging although this was not the
primary aim of the study. No biopsy
evidence of cancer was identified in
the treated regions in 30 of 39 men
who were biopsied at six months and
36 of the 39 were free of clinically
significant cancer. After re-treatment in
four men, a total of 39 patients had no
imaging evidence of disease at 12
months.
USHIFU is a privately held, venture-
backed healthcare company. US HIFU
is committed to treating prostate
cancer using HIFU with the Sonablate
500, a minimally invasive, outpatient
procedure.
Currently, the device is not approved
in the US but it is available for the
treatment of prostate cancer in more
than 30 countries.
HIFU (HIGH INTENSITY FOCUSED
ULTRASOUND) EQUIPMENTS
Sonalleve MR-HIFU Fibroid Therapy
system by Philips which offers a non-
invasive alternative to the traditional
surgical treatments for uterine fibroids
in women.
Exablate 2000 by Insightec for uterine
fibroids;
Sonablate by Focus for prostate
cancer on trial in US, approved
elsewhere;
Ablatherm by EDAP-TMS for prostate
cancer on trial in US, approved
elsewhere;
OTHER DEVELOPMENTS
Insurance Claims Filing Services (ICFS
– www.icfstx.com) specializes in
assisting US citizens with filing
insurance when care has been
received internationally. They have
had some success in securing
reimbursement for a number of HIFU
patients for procedures done outside
the country.
